TARSONS share price & delivery %

Filings & corporate actions

19 results filed

CSV

Next results · Q2 FY27

Expected 5 Nov 2026 – 12 Nov 2026

Estimate: filed 36–43 days after quarter end, last 4 times

Dividend

₹2.00 per share · last 20 Sept 2024

2026

10 AugresultsResults · Q1 FY27 · consolidated and standalone-5.2%NSE
20 JulshareholdingShareholding · 30 Jun 2026-2.1%NSE
22 MayresultsResults · Q4 FY26 · consolidated and standalone-1.8%NSE
9 AprshareholdingShareholding · 31 Mar 2026-2.1%NSE
6 FebresultsResults · Q3 FY26 · consolidated and standalone-2.5%NSE
8 JanshareholdingShareholding · 31 Dec 2025-1.5%NSE

Reaction to results · all yearsrose on day 0 in 3 of 19 CSV

Quarter	Filed	Day 0	+5D	+20D	Rel vol
Q1 FY27	10 Aug 2026	-5.2%	+7.4%	+3.7%	1.0×
Q4 FY26	22 May 2026	-1.8%	-5.1%	+20.3%	17.1×
Q3 FY26	6 Feb 2026	-2.5%	-9.6%	-11.3%	1.0×
Q2 FY26	12 Nov 2025	-6.9%	-14.7%	-11.5%	4.7×
Q1 FY26	12 Aug 2025	-4.2%	-8.8%	-13.0%	1.1×
Q4 FY25	29 May 2025	-2.9%	-3.9%	-3.2%	1.3×
Q3 FY25	14 Feb 2025	-2.2%	-6.2%	-5.4%	1.0×
Q2 FY25	8 Nov 2024	-3.3%	-9.9%	-1.5%	0.7×
Q1 FY25	14 Aug 2024	-5.9%	+2.2%	-1.7%	2.7×
Q4 FY24	31 May 2024	-3.1%	-1.4%	+19.1%	1.1×
Q3 FY24	13 Feb 2024	-0.4%	+2.1%	-15.6%	0.7×
Q2 FY24	11 Nov 2023	+1.2%	-1.7%	-3.3%	0.2×
Q1 FY24	11 Aug 2023	-4.7%	-12.0%	-10.1%	4.1×
Q4 FY23	28 May 2023	+0.2%	+0.3%	+3.7%	1.4×
Q3 FY23	12 Feb 2023	-8.9%	-13.6%	-20.2%	5.3×
Q2 FY23	5 Nov 2022	-7.6%	-10.6%	-5.5%	5.1×
Q1 FY23	6 Aug 2022	-9.7%	-10.5%	-1.5%	5.8×
Q4 FY22	27 May 2022	+4.1%	+0.5%	+0.8%	1.6×
Q3 FY22	7 Feb 2022	-5.5%	-7.2%	-10.3%	1.4×
Average		-3.7%	-5.4%	-3.5%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV

Revenue YoY+20.7%

Profit YoY-181.0%

Interest cost YoY+17.9%

Revenue QoQ-8.8%

Profit QoQ-134.5%

CAGR	2Y	3Y	4Y	5Y	6Y	7Y
Revenue	—	—	—	—	—	—
Profit	—	—	—	—	—	—

Key data

CSV

Open332.75

Day range329.55 – 349.00

52-week range164.45 – 375.00

From 52w high-11.6%

RSI (14)52.4

ATR (14)16.78

Volume1.66L

Avg volume (20D)4.18L

Rel volume0.40×

Volatility (1Y)51.3%

Turnover₹5.5Cr

SMA 50 / 200327.55 / 248.01

Delivery percentage

Latest · 6 Oct 202654.4%

20-day avg40.6%

1-year avg49.3%

Percentile (own history)63rd

Range4.0–97.6%

Sessions1,202

Over the last 20 sessions TARSONS settled 40.6% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 49.3%, so recent sessions are running 8.7 points lower than usual. The latest session ranks higher than 63% of the 1,202 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

IndustryMedical Equipment & Supplies

PeersMOLBIO POLYMED FISCHER LAXMIDENTL FABTECH GKB

Performance returns

CSV

	1D	1W	1M	3M	6M	1Y
Price	-1.28%	-1.88%	-1.44%	+11.89%	+82.60%	+7.94%

Valuation

CSV

Market cap₹1,765 Cr

P/E (TTM)159.0

EPS (TTM)2.09

Shares outstanding5.32Cr

Listed26 Nov 2021

Ownership

CSV

Promoter47.30%

Promoter Δ QoQ0.00 pp

Public52.70%

FII0.16%

DII0.10%

Pledged0.00%

Quarterly results · consolidated

CSV

	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue (₹ Cr)	102.3	107.9	120.9	110.2
YoY chg	+3.1%	+12.8%	+7.3%	+20.7%
Net profit (₹ Cr)	3.3	5.0	4.2	(1.4)
YoY chg	-67.7%	-4.2%	-59.0%	-181.0%
Net margin	3.2%	4.7%	3.5%	-1.3%
EPS	0.62	0.95	0.79	-0.27

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 47.30% · public 52.70%

2021-112026-06

Promoter
Public and others

Promoter: 47.30%
Public: 52.70%
Promoter change: 0.00 pp
Filed: 20 Jul 2026

FII: 0.16%
DII: 0.10%
Promoter pledged: 0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV

₹ crore, as filed

	Q4 FY22	Q3 FY24	Q4 FY24^A	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25^A	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26^A	Q1 FY27
Revenue from operations	84.9	61.8	105.7	84.8	99.2	95.7	112.7	91.4	102.3	107.9	120.9	110.2
Other income	2.6	3.2	3.4	2.9	8.4	0.8	3.8	3.3	5.8	8.4	6.6	6.0
Total income	87.5	65.0	109.1	87.7	107.7	96.5	116.5	94.7	108.1	116.3	127.5	116.2
Total expenses	48.3	51.5	92.1	81.4	92.8	88.5	100.9	91.7	102.5	107.5	122.0	117.5
└ Finance costs	0.5	2.5	4.3	4.3	4.8	5.0	5.2	5.1	5.2	6.0	6.3	6.3
└ Depreciation	7.2	10.1	12.3	11.0	14.0	17.4	20.0	19.9	22.5	25.0	29.1	27.0
Profit before tax	39.2	13.6	17.0	6.3	14.9	8.0	15.6	3.0	5.6	7.5	5.8	(1.3)
Tax expense	9.8	3.6	6.7	2.3	4.6	2.8	5.4	1.2	2.3	2.5	1.6	0.1
Net profit	29.5	9.9	10.3	4.0	10.3	5.3	10.2	1.8	3.3	5.0	4.2	(1.4)
EPS	5.69	1.87	1.94	0.75	1.93	0.99	1.92	0.34	0.62	0.95	0.79	-0.27
Net margin	34.69%	16.06%	9.76%	4.74%	10.37%	5.50%	9.05%	1.95%	3.25%	4.67%	3.46%	-1.31%
PBT margin	46.18%	21.93%	16.12%	7.45%	14.98%	8.41%	13.82%	3.32%	5.46%	6.96%	4.77%	-1.20%
Tax rate	24.89%	26.75%	39.47%	36.42%	30.77%	34.65%	34.47%	41.19%	40.58%	32.92%	27.53%	—

^A audited · ^R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 10 Aug 2026.

TARSONS at a glance

TARSONS closed at ₹331.65 on 6 Oct 2026, -1.28% on the day, +7.9% over one year, 11.6% below its 52-week high of ₹375.
Delivery was 54.4% of traded quantity on 6 Oct 2026, the 63rd percentile of its own 1,202 sessions with a reading (20-session average 40.6%, 1-year average 49.3%).
Market capitalisation is ₹1,765 crore at a trailing P/E of 159.0 (trailing EPS ₹2.09).
Q1 FY27 results (consolidated, filed 10 Aug 2026): revenue ₹110 crore (+20.7% year on year), net profit ₹-1 crore (-181.0%); the price moved -5.2% on the first session after.
Promoters held 47.30% at 30 Jun 2026, unchanged on the previous filing.
Q2 FY27 results are expected between 5 Nov 2026 and 12 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV

Macro sectorHealthcare

Basic industryMedical Equipment & Supplies

ISININE144Z01023

SeriesEQ

Listed26 Nov 2021

History from26 Nov 2021

Sessions1,205

Turnover rank#913

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Equipment & Supplies

CSV

All Healthcare Equipment & Supplies stocks on the NSE All Healthcare stocks on the NSE